Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-02-02 12:57 Tx date 2024-01-29 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+29,043 vol |
2,050,552 | |
Filed 2024-02-02 12:57 Tx date 2024-01-29 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-62,500 vol |
2,364,277 | |
Filed 2024-01-05 17:18 Tx date 2024-01-02 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+75,513 vol |
2,021,509 | |
Filed 2024-01-05 17:18 Tx date 2024-01-02 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-162,500 vol |
2,426,777 | |
Filed 2023-12-27 21:33 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+192,333 vol |
1,945,996 | |
Filed 2023-12-27 21:32 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
-409,220 vol |
2,589,277 | |
Filed 2023-12-27 21:30 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+1,940,308 vol |
2,998,497 | |
Filed 2023-12-27 21:29 Tx date 2023-12-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+1,414,945 vol |
4,419,555 | |
Filed 2023-08-23 09:23 Tx date 2023-08-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,463.175
-139,509 vol $0.075 each |
1,753,663 | |
Filed 2023-08-23 09:22 Tx date 2023-08-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-16,875
-225,000 vol $0.075 each |
1,058,189 | |
Filed 2023-08-23 09:22 Tx date 2023-08-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,875
+225,000 vol $0.075 each |
1,893,172 | |
Filed 2023-07-06 17:56 Tx date 2023-05-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-6,821.55
-90,954 vol $0.075 each |
1,692,409 | |
Filed 2023-07-06 17:55 Tx date 2023-05-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$68,215
+90,954 vol $0.75 each |
1,408,468 | |
Filed 2023-07-06 17:55 Tx date 2022-09-15 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-2,134.05
-28,454 vol $0.075 each |
314,923 | |
Filed 2023-07-06 17:54 Tx date 2022-09-15 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,134
+28,454 vol $0.075 each |
1,317,514 | |
Filed 2023-07-06 17:53 Tx date 2022-05-17 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-2,560.77
-28,453 vol $0.09 each |
405,877 | |
Filed 2023-07-06 17:51 Tx date 2022-05-17 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$2,560
+28,453 vol $0.09 each |
1,226,560 | |
Filed 2023-07-06 17:50 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-8,874.8026
-28,454 vol $0.3119 each |
184,330 | |
Filed 2023-07-06 17:50 Tx date 2021-09-15 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,874
+28,454 vol $0.3119 each |
1,198,107 | |
Filed 2023-07-06 17:48 Tx date 2022-08-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-4,062.50
-62,500 vol $0.065 each |
343,377 | |
Filed 2023-07-06 17:47 Tx date 2022-08-18 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,062
+62,500 vol $0.065 each |
1,289,060 | |
Filed 2023-07-06 17:45 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$11,483
+28,453 vol $0.4036 each |
1,169,653 | |
Filed 2023-07-06 17:45 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-11,483.6308
-28,453 vol $0.4036 each |
212,784 | |
Filed 2023-07-06 17:44 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+28,453 vol |
||
Filed 2023-06-30 19:08 Tx date 2022-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-4,687.50
-62,500 vol $0.075 each |
||
Filed 2023-06-30 19:07 Tx date 2022-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,687
+62,500 vol $0.075 each |
||
Filed 2023-06-30 19:03 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-78,160.545
-192,989 vol $0.405 each |
||
Filed 2023-06-30 19:02 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+192,989 vol |
||
Filed 2023-06-30 19:16 Tx date 2023-06-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-15,615.84
-260,264 vol $0.06 each |
1,656,393 | |
Filed 2023-06-30 19:15 Tx date 2023-06-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$24,553
+409,220 vol $0.06 each |
1,916,657 | |
Filed 2023-06-30 19:14 Tx date 2023-06-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-24,553.20
-409,220 vol $0.06 each |
1,294,968 | |
Filed 2023-06-30 19:12 Tx date 2022-12-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+818,440 vol |
1,704,188 | |
Filed 2023-06-30 19:11 Tx date 2022-12-22 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,345
+204,610 vol $0.075 each |
3,004,610 | |
Filed 2023-06-30 19:10 Tx date 2022-10-06 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+650,000 vol |
885,748 | |
Filed 2023-06-30 19:09 Tx date 2022-10-06 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$58,500
+650,000 vol $0.09 each |
2,800,000 | |
Filed 2023-06-30 19:08 Tx date 2022-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-4,687.50
-62,500 vol $0.075 each |
235,748 | |
Filed 2023-06-30 19:07 Tx date 2022-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$4,687
+62,500 vol $0.075 each |
1,396,689 | |
Filed 2023-06-30 19:05 Tx date 2022-01-27 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+250,000 vol |
298,248 | |
Filed 2023-06-30 19:04 Tx date 2022-01-27 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$292,500
+1,500,000 vol $0.195 each |
2,150,000 | |
Filed 2023-06-30 19:03 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
57 - Exercise of rights
|
$-78,160.545
-192,989 vol $0.405 each |
48,248 | |
Filed 2023-06-30 19:02 Tx date 2021-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+192,989 vol |
1,334,189 | |
Filed 2023-06-30 19:01 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
56 - Grant of rights
|
+241,237 vol |
241,237 | |
Filed 2023-06-30 19:00 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-06-30 19:00 Tx date 2021-03-15 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,250
+50,000 vol $0.485 each |
650,000 | |
Filed 2023-05-29 16:30 Tx date 2023-05-19 |
$LABS
MediPharm Labs Corp. |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$8,306
+110,748 vol $0.075 each |
1,251,948 | |
Filed 2019-01-14 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Holder: Strachan Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2019-01-14 Tx date 2019-01-07 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$270,007
+1,141,200 vol $0.2366 each |
1,141,200 | |
Filed 2019-01-14 Tx date 2019-01-08 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,200,000
+600,000 vol $2.00 each |
600,000 | |
Filed 2019-01-14 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Holder: Strachan Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,340,000 | ||
Filed 2019-01-14 Tx date 2019-01-07 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-270,007.92
-1,141,200 vol $0.2366 each |
0 | |
Filed 2019-01-14 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-10-31 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Holder: Strachan Family Trust (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
634,000 | ||
Filed 2018-10-31 Tx date 2018-10-01 |
$LABS
MediPharm Labs Corp. (formerly POCML 4 Inc.) |
Strachan, Keith
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,141,200 |